Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders
Study Details
Study Description
Brief Summary
The aim of this study is to determine whether treatment of temporomandibular joint is more effective than usual care in patients with chronic migraine and temporomandibular disorders to reduce pain.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The aim of this study is to determine whether treatment of temporomandibular joint added to the control group treatment and drug therapy patient base is more effective than just using the control group treatment and drug therapy in patients with chronic migraine and temporomandibular disorders to reduce pain and improve the quality of life related to health of patients.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: INTERVENTION Manual Therapy in temporomandibular joint and cervical region. Home physical therapy in temporomandibular joint and cervical region. |
Other: Manual therapy
6 treatments: 2 treatments for week
1 treatment = 30 minutes
Other: Home physical therapy
once a day: 15 minutes
|
Active Comparator: CONTROL Manual therapy in cervical region Home physical therapy in cervical region |
Other: Manual therapy in cervical region
6 treatments: 2 treatments for week
1 treatment = 30 minutes
Other: Home physical therapy in cervical region
once a day: 15 minutes
|
Outcome Measures
Primary Outcome Measures
- Headache Impact Test (HIT-6) [3 months]
Secondary Outcome Measures
- Visual Analogue Scale (VAS) [3 months]
- Quality of life (SF-36) [3 months]
- Sleep Quality [3 months]
Pittsburgh Sleep Quality Index
- Pain threshold pressure [3 months]
Pressure algometer in masticatory muscle (area trigeminal) and control point in area extra-trigeminal
- Pain catastrophizing scale (PCS) [3 months]
- Craniofacial Pain and Disability Inventory (CF-PDI) [3 months]
- Tampa scale of Kinesiophobia (TSK) [3 months]
- Tampa scale of Kinesiophobia of cranio-mandibular disorder (TSK-TCM) [3 months]
- Maximal Mouth Opening pain free [3 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Chronic migraine (ICHD_III beta, 2013)
-
Temporomandibular disorders (RDC/TMD)
Exclusion Criteria:
-
other neurological disease
-
psychiatric diseases
-
Physical therapy treatment in the last 6 months
-
dental treatment in the last 6 months
-
surgery or trauma in the orofacial region
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Universidad San Jorge | Zaragoza | Spain |
Sponsors and Collaborators
- Cardenal Herrera University
- Hospital Miguel Servet
Investigators
- Principal Investigator: Miriam Garrigós, Universidad San Jorge
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CM_TMD_1